About This Research Study
Chikungunya is a viral disease spread through mosquito bites, causing fever and severe joint pain, often accompanied by headache, muscle pain, nausea and rash. Tekton Research is now enrolling a clinical study evaluating a chikungunya vaccine for children. While two vaccines have been approved for adults and teens, this study focuses on the safety and immune response of a chikungunya vaccine in children ages 2 to 5. Qualified participants may be compensated for time and travel.
Eligible Participants…
- Must be 2 to 5 years old
- Must be in general good health
- Must have no prior history of Chikungunya
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.